Nervgen Pharma NGEN
NASDAQ NGEN
$1.50 -0.04 (-2.60%)
At close: Oct 21, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Receivables - Net (2024 - 2026)

Updated

Nervgen Pharma (NGEN) recorded Receivables - Net of $144,756 in the quarter ended Jun 30, 2026, up 112.2% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Receivables - Net (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Nervgen Pharma reported Receivables - Net of $57,848, down 80.9% from the prior year.

  • Across earlier years, Receivables - Net came in at $303,336 in the year ended Dec 31, 2024.
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Receivables - Net since the quarter ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Nervgen Pharma 108.50 Mn 7.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 140,921.95
Mar 31, 2026 67,154.64
Dec 31, 2025 59,019.18
Dec 31, 2024 289,412.38
API Access

Nervgen Pharma Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=NGEN&period=max&api_key=YOUR_API_KEY